Axial VC β Full Portfolio
53 tracked investments Β· listed companies and verified rows first
Adaptyv Bio develops technologies for protein engineering that enable the design and testing of new proteins for applications in medicine, industrial enzymes, and functional materials.
AI & Machine LearningBiotechDeep TechHealthtechLausanne, CH
Julian Englert(Founder)inDaniel Nakhaee-Zadeh Gutierrez(Founder)inRobert KapturGerard AntounSam Burns
Co-investorsHAWKTAILNeer Venture PartnersRheingau FoundersUnruly CapitalY CombinatorACE & Company+2 more
Aperiam Bio develops protein engineering services, using algorithms to design and optimize hyper-folding protein variants through mutagenesis, testing, and validation.
AI & Machine LearningBiotechDeep TechAustin, US
Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)Russell Durrett(Chief Business Officer)
Co-investorsCivilization Ventures Management, LlcOMX VenturesKdT Ventures
Co-investors8VC
Arda Therapeutics is a drug development company that uses single-cell computational biology to identify and eliminate pathogenic cells as a way to treat chronic diseases.
AI & Machine LearningBiotechDigital HealthLongevityMedical Devices
Adam Freund(Founder & Chief Executive Officer)inRemi-Martin Laberge(Founder & Chief Technology Officer)
Co-investorsGV (Google Ventures)
Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.
AI & Machine LearningBiotechMedical DevicesNatick, US
Edward Doherty(Executive Officer)Jessica McDonough(Director)Joaquim Trias(Executive Officer, Director)
BoardZeshan Muhammedi(Director)
Co-investorsMBX CapitalUlu VenturesEmbark Ventures
Big Hat Bio develops therapeutics under development across multiple programs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Peyton Greenside(Executive Officer, Director)Mark DePristo(Executive Officer, Director)
BoardFrancisco Gimenez(Director)inSteve Kafka(Director)Vineeta Agarwala(Director)inRobert Chess(Director)
Co-investors8VCAndreessen HorowitzBOLD LongevityFlucas VenturesGRIDS CapitalAME Cloud Ventures+1 more
BluumBio identifies and deploys naturally occurring enzymes from fungi, trees, and bacteria to remove industrial pollutants from soil, air, and water.
BiotechCleantechHealthtechImpact & Social GoodSan Francisco, US
Katherine French(Founder)in
Co-investorsOlive Tree CapitalOxonian VenturesY Combinator
Bristle provides digital tools and insights to help people assess and improve their oral health, positioning dental care as a preventive step toward overall wellness.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
David Lin(Founder)inBrian Maurer(Founder)inShivam Patel(Founder)in
Co-investorsR/GA VenturesY CombinatorInitialized Capital
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Marco Lobba(Founder)inMatthew Francis(Founder)in
Co-investorsCivilization Ventures Management, LlcIaso VenturesY CombinatorLongeVCMBX CapitalSocial Impact Capital
CHARM is a biotech company developing a next-generation menin inhibitor for acute myeloid leukemia (AML), designed to address resistance seen with first-generation approaches.
AI & Machine LearningBiotechHealthtech
Co-investorsF-Prime Capital PartnersNew Enterprise Associates (NEA)OrbiMedNVentures
Colorado Springs, US
Thaddaus Huber(Executive Officer, Director)
BoardRik Wehbring(Director)Michael Cantrell(Director)
Concerto develops microbial technologies inspired by microbial ecology, aiming to create products that protect human health, food, and the environment.
AgTechAI & Machine LearningBiotechDeep TechCambridge, US
Jared Kehe(Executive Officer, Director)Cheri Ackerman(Executive Officer, Director)Bernardo Cervantes(Executive Officer, Director)Vera Schroeder(Director)
BoardSarah Luppino(Director)in
Co-investorsExcelestar VenturesGolden SeedsHorizons VenturesISVMassVenturesM Ventures
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)Owl CapitalquadraScope Venture Fund
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
Co-investorsArtis VenturesCasa Verde CapitalNoeticOMX VenturesPsyMed VenturesRA Capital+3 more
Enable Medicine builds an integrated biological data platform that organizes and links clinical, spatial, cellular, and molecular data from patients and studies into a unified index to accelerate therapeutic discovery and diagnostics for researchers.
AI & Machine LearningBiotechData & InfrastructureMenlo Park, US
Sunil Bodapati(Executive Officer, Director)Aaron Mayer(Director)in
Co-investorsBreyer CapitalInertia Ventures
The site presents Thai-language promotional content for online slot ("ΰΈͺΰΈ₯ΰΉΰΈΰΈΰΉΰΈ§ΰΉΰΈΰΈΰΈ£ΰΈ") gambling, listing direct-web slot sites with automatic wallet deposits/withdrawals and hundreds of games.
Co-investorsBantam GroupHyphen Capital
Glyphic Biotechnologies develops ProSEβ’, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Joshua Yang(Founder & CEO)Daniel Estandian(Founder)Ed Boyden(Founder)Josh Yang(Founder)in
BoardCraig Asher(Director)inJimmy Yun(Director)
Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcFoundersX VenturesLongeVCModi Ventures+3 more
Co-investorsAngel ForumCognition FundSwan Venture FundWUTIF CapitalYork Angel Investors Inc.
Co-investorsBlue Bear Ventures
Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
AI & Machine LearningBiotechDeep TechBrooklyn, US
Josh Haimson(Executive Officer, Director)inBen Birnbaum(Ph.D.)inAlexander Taylor(Ph.D.)in
BoardRohan Ganesh(Director)in
Co-investorsAlleyCorpAndreessen HorowitzCoalition OperatorsLux CapitalObvious VenturesAlley Robotics Ventures+3 more
Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization.
AI & Machine LearningBiotechMedical Devices
Lance Hepler(Founder)inKatie Pfeiffer(Founder)Michael Gibbons(Founder)Wyatt McDonnell(Founder)david jaffe(Founder)
Co-investorsCivilization Ventures Management, LlcPlayground Global
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
TIMOTHY CRAVEN(Executive Officer, Director)TOBY PASSIOURA(Executive Officer, Director)Tim Craven(CEO)Toby Passioura(CSO)Glen McIntyre(COO)GLEN MCINTYRE(Executive Officer, Director)
Co-investorsCivilization Ventures Management, LlcMRL Ventures FundPlayground GlobalvenBio PartnersvenBio Global Strategic
FODZYME develops an enzyme powder supplement that breaks down FODMAPs in food, particularly fructans found in garlic, onions, and wheat, for people with digestive sensitivities.
BiotechConsumerFoodTechHealthtechWellness & FitnessBoston, US
Anjie Liu(Founder)inDavid Hachuel Gurska(Founder)in
Co-investorsY Combinator
Lyell is a clinical-stage biotech developing next-generation CAR T-cell product candidates intended as one-time treatments for patients with cancer, targeting both hematologic malignancies and solid tumors.
BiotechHealthtech
Co-investorsvenBio Partners8VC
Machine learning and data platform for understanding how diseases fight back and resist therapies
Nuanced Health operates a preclinical drug discovery and development platform that humanizes the mouse microbiome to recreate the biological heterogeneity of human populations.
AI & Machine LearningBiotechDeep Tech
Co-investorsFREEFLOWOpen Field Capital
Wellness & FitnessLos Angeles, US
Kyle Pierce(Executive Officer, Director)inMorgan Hewett(Executive Officer, Director)
Co-investorsBread And Butter Ventures, LlcTechstarsBread Butter VenturesBright VenturesCollab CapitalM13+1 more
Papa is a platform that connects older adults and families with trained companion caregivers for in-home companionship and support services.
ConsumerDigital HealthHealthtechSocialWellness & FitnessMiami, US
Andrew Parker(Founder/CEO)inAlfredo Vaamonde(Co-Founder)inAndrew(CEO)in
Co-investorsComcast VenturesIntegra GroupeMagnify VenturesSoftBank Vision FundThe Chernin Group (TCG Crypto)Y Combinator+2 more
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Robert DiFazio(Founder)inJuliana Hilliard(Founder)in
Co-investorsAIX VenturesBreakout VenturesHumba VenturesImmeasurableJulian CapitalMetaplanet+5 more
Parallel Health is a licensed teledermatology practice offering the MD-03 Protocol, a three-step system combining whole genome microbiome sequencing, 1:1 clinical consultations, and custom phage-based serums.
BiotechDigital HealthDirect to Consumer
Co-investorsFirst In VenturesHyphen Capital
Potion creates automation and workflow solutions for beauty and personal care companies to reduce time spent on repetitive tasks.
AI & Machine LearningConsumerEnterprise SoftwareMarketing TechSaaSSan Francisco, US
Yahya Syed(Founder)inHejab Malik(Founder)inAlex Stec(Founder)in
Co-investorsHAWKTAILY Combinator
Reference Medicine supplies quality-controlled human oncology specimens to research teams, sourcing samples across cancer indications from IRB/EC-accredited institutions worldwide.
B2B MarketplacesBiotechHealthtech
Co-investorsMetaplanet
Replay develops gene therapies for patients with rare genetic diseases.
BiotechHealthtechLongevity
Lachlan MacKinnon(CEO and Founder)Adrian Woolfson(Founder)Robert Coffin(Executive Chairman)Maria Castner-Miller(General Counsel)Renata Martin(VP & Head of Gene Therapy)Saurabh Sharma(VP & Head of CMC)
Co-investorsArtis VenturesOMX VenturesSolari Capital
Advanced ManufacturingAlameda, US
Neeka Mashouf(Executive Officer, Director)Leila Mashouf(Executive Officer, Director)
BoardDaria Hosseinyoun(Director)Rohini Finch(Director)
BiotechNew Haven, US
Aaron Ring(Manager)Beatrice McQueen(Executive Officer)
BoardJim Tananbaum(Manager)
Co-investorsARCH Venture Partners
Simcha Therapeutics is a clinical-stage biotech company developing protein therapeutics, with pipeline programs focused on cytokines and immunotherapies for oncology.
BiotechHealthtechNew Haven, US
Aaron Ring(Executive Officer, Director)Beatrice McQueen(Chief Operating Officer)Sanuj Ravindran(Chief Executive Officer)Jeremy Barton(Chief Medical Director)Hirdesh Uppal(Senior Vice President Translational Research and Development Sciences)Joseph Catino(Executive Officer)
Co-investorsConnecticut InnovationsPfizer Venture InvestmentsSR One Capital Management
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.
AI & Machine LearningBiotechMedical Devices
Co-investorsAIX VenturesFoothill VenturesMitsui Global InvestmentBoxOne VenturesDimension Capital
Stipple Bio develops targeted oncology therapies that act on tumor-specific cell surface epitopes to expand druggable targets and improve therapeutic index for cancer patients.
BiotechHealthtechCambridge, US
Aaron Ring(Co-founder)Aashish Manglik(Co-founder)Jeff Landau(Chief Executive Officer)inRoland Gendron(Chief Business Officer)inMichelle Zhang(Chief Scientific Officer)in
BoardVineeta Agarwala(Director)in
Co-investorsRA CapitalAndreessen HorowitzMagnetic VenturesOMX VenturesGV (Google Ventures)LoLa Capital Partners+1 more
SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
BiotechHealthtechBoston, US
Elliot Tague(Founder)inNathan Tague(Founder)in
Co-investorsY Combinator
Talus is a drug discovery company with a proprietary platform that measures and modulates the regulome β the transcription factors, cofactors, and splicing regulators controlling gene expression β in live cells using functional proteomics and AI models.
AI & Machine LearningBiotechDeep Tech
Alex Federation(Ph.D.)Christopher Joyce(MBA)Lindsay Pino(Ph.D.)Michelle BriscoeWill Fondrie(Ph.D.)
Thatch is an all-in-one health benefits platform that uses an ICHRA model, letting employers set a tax-free healthcare budget while employees choose their own insurance plans and spend the allowance on health and wellness services via a marketplace and a Thatch Visa debit card.
FintechHealthtechInsurTech
ThinkBioscience develops small-molecule drugs aimed at historically difficult drug targets, using synthetic biology to identify novel mechanisms of biomolecular engagement.
BiotechDeep Tech
Co-investorsAV8 VenturesBuff Gold VenturesCU Healthcare Innovation FundWireframe Ventures
Tilda Research provides AI-powered teammates designed to streamline clinical trial operations for sponsors, contract research organizations, and research sites by automating data management and workflow processes.
AI & Machine LearningHealthtechMedical Devices
Ram Yalamanchili(Founder/CEO)
Co-investors8VCOptum VenturesStorm Ventures
Trestle Biotherapeutics develops bioengineered implantable tissues designed to treat end-stage renal disease, aiming to get patients off dialysis and eventually provide replacement organs.
BiotechDeep TechHealthtechMedical DevicesSan Diego, US
Ben Shepherd(Founder)inAlice Chen(Founder)inAlice Chen, PhDBen Shepherd, PhD(CEO)
Co-investorsY Combinator
Zeit Medical develops a wearable headband with AI-powered sensors that detects strokes in real time and automatically alerts emergency services, targeting patients at high risk for stroke who may be asleep or unable to call for help themselves.
HealthtechMedical DevicesSan Francisco, US
Orestis Vardoulis(Founder)inUrs Naber(Founder)in
Co-investorsCitta CapitalY CombinatorGaingelsSeedToB
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.